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Breastfeeding has been linked to a reduction in the prevalence of allergy and asthma. How-
ever, studies on this relationship vary in outcome, which may partly be related to differences
in breast milk composition. In particular breast milk composition may differ between allergic
and non-allergic mothers. Important components that may be involved are breast milk pro-
teins, as these are known to regulate immune development in the newborn. The objective of
this study was therefore to explore differences in the proteins of breast milk from 20 allergic
and non-allergic mothers. The results from this comparison may then be used to generate
hypotheses on proteins associated with allergy in their offspring.
Methods
Milk samples from allergic and non-allergic mothers were obtained from the PIAMA project,
a prospective birth cohort study on incidence, risk factors, and prevention of asthma and in-
halant allergy. Non-targeted proteomics technology, based on liquid chromatography and
mass spectrometry, was used to compare breast milk from allergic and non-
allergic mothers.
Results
Nineteen proteins, out of a total of 364 proteins identified in both groups, differed significant-
ly in concentration between the breast milk of allergic and non-allergic mothers. Protease in-
hibitors and apolipoproteins were present in much higher concentrations in breast milk of
allergic than non-allergic mothers. These proteins have been suggested to be linked to aller-
gy and asthma.
PLOS ONE | DOI:10.1371/journal.pone.0122234 March 23, 2015 1 / 11
a11111
OPEN ACCESS
Citation: Hettinga KA, Reina FM, Boeren S, Zhang L,
Koppelman GH, Postma DS, et al. (2015) Difference
in the Breast Milk Proteome between Allergic and
Non-Allergic Mothers. PLoS ONE 10(3): e0122234.
doi:10.1371/journal.pone.0122234
Academic Editor: Andrea S. Wiley, Indiana
University, UNITED STATES
Received: September 9, 2014
Accepted: February 10, 2015
Published: March 23, 2015
Copyright: © 2015 Hettinga et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and the full dataset is available as
supplementary table (S2 Table).
Funding: The PIAMA study is supported by The
Netherlands Organization for Health Research and
Development, The Netherlands Organization for
Scientific Research, The Netherlands Lung Fund,
The Netherlands Ministry of Spatial Planning,
Housing, and the Environment, and The Netherlands
Ministry of Health, Welfare, and Sport. No additional
funding was received for the proteomics study
described in this paper. The funders of the PIAMA
study had no role in study design, data collection and
Conclusions
The non-targeted milk proteomic analysis employed has provided new targets for future
studies on the relation between breast milk composition and allergy.
Introduction
Because of a range of health benefits, the WHO recommends to breastfeed babies exclusively
for the first 6 months of life [1]. In addition to nutritional benefits, it is important for gut matu-
ration and modulation of inflammatory response [2–4]. Furthermore, breast milk may directly
modulate the newborn’s immune system, amongst others by delivering antibodies specific for
microbes and other antigens present in the mother’s indoor and outdoor environment [2, 4, 5].
Breastfeeding has been linked to a decrease [3, 5] as well as increase [6] in the occurrence of
allergy and asthma. A recent review on the relation between breastfeeding and allergy conclud-
ed that there are shortcomings in the current evidence for a clear relationship, as studies
showed a wide variety in results [7]. One of the hypotheses put forward in this review is that
the variation in composition of breast milk may be related to the lack of a clear relationship be-
tween breastfeeding and allergy. The same uncertainty can be seen when the allergy status of
the mother is taken into account. Some studies showed a more pronounced protection with a
positive family history of asthma or atopy [8, 9]. On the other hand, it has been reported that
breast-fed children had higher immunoglobulin E (IgE) levels compared with never breast-fed
children, if their mothers had high IgE levels [10]. This controversy may in part be due to indi-
vidual variations in the levels of immunological components in breast milk of allergic and of
non-allergic mothers. Different components, including leukocytes, cytokines, immunoglobu-
lins and fatty acids, have all been suggested as potential candidates for this effect [11]. For ex-
ample, IgG–antigen immune complexes have been linked to allergy and asthma prevention [4],
although other milk proteins, including α-lactalbumin and β-lactoglobulin, have also previous-
ly been linked to a reduction in prevalence of allergy and asthma [12]. In addition, cytokines in
milk, including transforming growth factor-β (TGF-β) and interleukin-10 (IL-10), have previ-
ously been linked to tolerance induction [4].
Previous research aiming to find components in breast milk of allergic mothers that could
explain the reduction in allergy in their offspring has focused on specific compounds thought
to affect allergy or tolerance induction. To study these components, targeted techniques have
been used. With recent developments in the field of non-targeted proteomics, it has become
possible to screen many hundreds of proteins simultaneously instead of having to target specif-
ic preselected proteins.
In this paper, we report the use of non-targeted proteomics to study differences in the prote-
ome of breast milk from allergic and non-allergic mothers.
Methods
The procedure followed during the experimental phase is detailed below. A general flow dia-
gram of the process is shown in Fig. 1.
Milk samples
Samples analysed were obtained from the PIAMA project, which is a prospective birth cohort
study on incidence, risk factors, and prevention of asthma and inhalant allergy [13].
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At the time of recruitment, the pregnant mothers filled in a validated screening question-
naire on allergy [14]. Mothers reporting at least one of the following: (a history of) asthma, cur-
rent hay fever, current allergy for pets, or current allergy for house dust or house dust mite
were defined as ‘allergic’ and mothers reporting that they had none of these complaints were
defined as ‘non-allergic’. Blood samples were obtained from a sub-group of the mothers with
self-reported asthma or allergies and their allergic status was confirmed by tests for specific IgE
against house dust mite. Only mothers with confirmed house dust mite (HDM) allergy were se-
lected in the allergic group. HDM allergy was chosen, given that HDM is one of the most com-
mon allergens [8] and exposure to this allergen cannot be prevented.
Breast milk samples were taken when the infants were 2 to 4 months old. For this study, 20
samples were analysed, 10 samples from mothers with confirmed HDM allergy with high
HDM allergen exposure, and 10 frommothers who reported no asthma or allergies, with a sim-
ilar HDM allergen exposure. This number is based on a power calculation, aiming at picking
up a 5-fold difference, a standard deviation of the same size, an alpha of 0.05, and beta of 0.20.
The milk samples were collected in small plastic cups, either by manual pressure or by using a
breast pump. The samples were stored at -80°C. Details on sample collection (time and mode
of collection) can be found in S1 Table.
Ethics Statement
This research was performed in accordance with the ethical principles for medical research in-
volving human subjects outlined in the Declaration of Helsinki. The study protocol was ap-
proved by the Medical Ethics Committees of the participating institutes (RotterdamMEC
Fig 1. Overview of experimental procedure.
doi:10.1371/journal.pone.0122234.g001
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132.636/1994/39 and 137.326/1994/130; Groningen MEC 94/08/92; Utrecht, MEC-TNO oor-
deel 95/50). All parents gave written informed consent.
Removal of fat and casein
As the presence of fat and casein disturbs the proteomics analysis, these components were re-
moved from milk, to obtain a transparent liquid called milk serum. Samples were first thawed
at room temperature and then approx. 3mL of each was ultracentrifuged for 90min at 100,000g
and 30°C, in a Beckman L-60 ultracentrifuge to separate milk serum.
Protein quantification
Prior to preparing the samples for analysis, their protein content was measured using a BCA
Protein Assay kit (Thermo, San Jose, CA, USA), to ensure that the same amount of protein
(10 μg) was loaded onto each filter.
Sample preparation for proteome analysis
The milk serum samples were prepared for LC/MSMS analysis according to the procedure de-
scribed by Lu et al. [15].
First, 20μL of serum was diluted with 180μL of a solution of 100mM Tris/HCl (pH 8) con-
taining 4% SDS and 0.1M DTT and then heated for 10min at 95°C. Afterwards, 10μL of each
sample was loaded onto a Pall 3K omega filter and centrifuged at 20,000g for 1 min. Then,
100μL of a solution of 8M urea in 100mM Tris/HCl (solution A) was added and the device was
centrifuged for 30 min. Next, 100μL of 0.05M iodoacetamide in solution A was added, followed
by centrifugation for 1 min and incubation at room temperature for 30 min, and then another
30min of centrifugation. After that, each filter was washed with 110, 120 and 130μL respective-
ly of solution A, and centrifuged for 30 min after each washing step. Finally, 140μL of 0.05M
NH4HCO3 (solution B) was added, followed by centrifugation for 30min. The filter was then
transferred to a clean low-binding microcentrifuge tube, and 1μL sequencing-grade trypsin
(Roche, Germany) in 100μL solution B was added to each sample. The filters were incubated
overnight at room temperature and then centrifuged for 30 min. Finally, 3.5μL of 10% TFA in
water was added to each tube to reach a pH of 2–4.
LC-MS/MS
Samples were analysed with LC-MS/MS by the department of Biochemistry at Wageningen
University. Samples were analysed by injecting 18μL of sample over a 0.1032mm Prontosil
300-3-C18H (Bischoff, Germany) pre-concentration column (prepared in house), at a maxi-
mum pressure of 270bar. Peptides were eluted from the pre-concentration column onto a
0.10200mm Prontosil 300-3-C18H analytical column, with an acetonitrile gradient at a flow
of 0.5μL/min. The gradient consisted of an increase from 9% to 21% acetonitrile in water with
1mL/L formic acid in 100min, followed by an increase in the percentage acetonitrile to 34%
(with 68% water and 1mL/L formic acid) in 26 min, which was increased further to 50% aceto-
nitrile in 3 min. Between the pre-concentration and analytical column, an electrospray poten-
tial of 3.5kV was applied directly to the eluent via a solid 0.5mm platina electrode fitted into a
P777 Upchurch microcross. Full scan positive mode FTMS spectra were measured between m/
z 380 and 1400 on a LTQ-Orbitrap (Thermo electron, San Jose, CA, USA). MSMS scans of the
four most abundant multiply-charged peaks in the FTMS scan were recorded in data-depen-
dent mode in the linear trap (MSMS threshold = 5,000).
Milk Proteome of Allergic and Non-Allergic Mothers
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Peptide and protein identification
Each run with all MSMS spectra obtained was analysed with MaxQuant v.1.2.2.5 as described
before [16]. Methionine oxidations, acetylation of protein N termini, and de-amidation of N
and Q were specified as variable modifications. Carboxamidomethylation of cysteines was set
as a fixed modification (enzyme trypsin, 2 missed cleavages, peptide tolerance 6 ppm, fragment
ions tolerance 0.5 Da). The human Uniprot database (downloaded March 2012), as well as a
set of protein sequences of common contaminants, was used. In addition, MaxQuant created a
decoy database consisting of reversed sequences to calculate the false discovery rate (FDR). The
maximum FDR was set to 0.01 on peptide and protein level. Minimum required peptide length
was six amino acids. Finally, proteins were identified based on minimally 2 distinct peptides of
which at least one should be unique and one should be unmodified. All known contaminants
(i.e. keratins, trypsin), and proteins detected in less than half of the samples, were removed
from the set of proteins identified. The GO-annotation of these proteins was determined using
DAVID GO [17].
Full proteome quantification
The quantification of the full proteome is based on the extracted ion current and is taking the
whole three-dimensional isotope pattern into account, using peak intensities of all measured
isotopes [18]. At least two quantitation events were required for a quantifiable protein. If a pro-
tein was not detected in a specific sample, the value was set to 103 (minimum detection level).
MaxQuant was used with two different algorithms for quantification, IBAQ and LFQ [19]. In-
tensity based absolute quantification (IBAQ) estimates the absolute amount of a protein as the
sum of the intensities of all peptides, divided by the number of tryptic peptides that can theo-
retically be generated. Label-free quantification (LFQ) is an algorithm that calculates relative
protein amounts, by using several layers of normalization. These normalization steps make
LFQ better than IBAQ for comparison between samples, whereas IBAQ is more suitable as an
indicator for absolute concentration. Proteins had to have at least three valid LFQ intensities in
either the allergic or non-allergic group in the final results.
Statistical analysis
Perseus software v.1.2.0.16 was used to test for significant differences between groups. The
ratio between the concentration found in allergic mothers and non-allergic mothers was calcu-
lated as the difference (on 10log scale) of LFQ intensities. Differences between groups were then
statistically tested using two-tailed t-test, correcting for multiple testing using permutation-
based FDR [20].
Results
Table 1 shows that the demographic characteristics of the allergic and non-allergic mothers
were very similar. Also parameters for dietary intake did not differ significantly between the
mothers (data not shown).
A total of 364 proteins were identified and quantified in all human milk samples together.
Of these proteins, 357 were found in the the milk of allergic mothers, and 355 in the milk of
non-allergic mothers, with an overlap of 348 proteins. Only 9 proteins were uniquely found in
the milk of allergic mothers and 7 proteins were uniquely found in the milk of non-allergic
mothers (for details, see S2 Table). Below, the qualitative and quantitative differences in the
proteome are presented.
Milk Proteome of Allergic and Non-Allergic Mothers
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Qualitative differences in the proteome
In order to examine the function of the proteins, annotation according to gene ontology (GO)
was performed using the online tool DAVID [17], as shown in Table 2. About one-third of all
proteins have a GO annotation that is related to the immune system (including response to
wounding, inflammatory response, and apoptosis).
Quantitative differences in the proteome
First, we compared the differences in the proteome between allergic and non-allergic mothers.
Fig. 2 shows the geometric mean 10log-ratio of the protein LFQ values of the milk of allergic
mothers over that of non-allergic mothers. This figure shows the over-expressed proteins in al-
lergic mothers on the right, and those under-expressed on the left. A total of 19 proteins were
significantly different between allergic and non-allergic mothers (for details, see S2 Table).
None of the proteins that were uniquely found in the allergic or non-allergic mothers were
among the significantly different proteins. This is due to the fact that all proteins uniquely
Table 2. Overview of the most abundant GO annotation cluster (biological process) of the proteome
of milk samples from allergic and non-allergic mothers.
GO annotation cluster Protein count
Non-allergic Allergic
Response to wounding 53 52
Carbohydrate catabolic process 29 28
Homeostasis 20 20
Coenzyme metabolic process 21 20
Cellular carbohydrate biosynthetic process 14 13
Regulation of apoptosis 45 44
Response to extracellular stimulus (nutrients) 17 15
Inﬂammatory response 35 36
Hydrogen peroxide metabolic process 16 15
Response to organic substance 44 42
doi:10.1371/journal.pone.0122234.t002
Table 1. Overview of the main characteristics of the allergic and non-allergic mothers (either mean +/-





Age mother (years) 30.3 +/- 2.9 31.4 +/- 3.8
Age baby at breast milk sampling (days) 101 +/- 17 101 +/- 16
Gestational age (weeks) 40.2 +/- 1.1 40.6 +/- 0.8
Gestational or non-gestational maternal diabetes (yes/
no/data not available)
0/5/5 0/7/3
Education level mother (low/medium/high) 3/4/3 3/3/3
Male babies 7 7
Atopic father 3 4
Smoking during pregnancy 1 0
Multiparity 5 7
Pets during pregnancy 4 4
doi:10.1371/journal.pone.0122234.t001
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found in either group were very close to the detection limit, and that missing values were im-
puted with the detection limit for the statistical analysis.
We visualized whether these significant differences in protein intensity between the two
groups of mothers were due to a few outliers or consistent differences between the groups, by
plotting the data of individual mothers for five proteins. The five proteins were chosen to have
relatively abundant proteins, representing two interesting biological functions (protease inhibi-
tors and transport proteins), with large differences between the two groups. Additionally, we
present two proteins that have higher and lower concentrations in allergic mothers compared
to non-allergic mothers. Fig. 3 shows that for these five proteins, statistical differences were
due to systematic differences between groups and not due to outliers.
Discussion
Overview of the breast milk proteome
Our proteomic study in breast milk of allergic and non-allergic lactating mothers shows that
their proteomes are almost the same. This is in line with our observation that the proportion of
proteins involved in the same biological processes is similar for the milk samples of allergic and
non-allergic mothers (Table 2). In the statistical comparison, none of the 16 proteins that was
uniquely identified in one of the groups of mothers was found to differ significantly. This can
be explained by the fact that the concentrations of these proteins in the group in which the pro-
tein was present were often low and close to the detection limit, and missing values were im-
puted with the detection limit to enable statistical comparison. Of interest, the quantitative
Fig 2. Overview of the differences in the proteome of milk from allergic and non-allergic mothers. Pink dots mark proteins that show significantly
different concentrations between allergic and non-allergic mothers” while proteins marked with blue dots were not statistically different. Abbreviations are
gene codes: TTR: Transthyretin; S100A1: S100 calcium-binding protein A1; NUCB2: Nucleobindin-2; CALB2: Calretinin; SLC9A3R1: Sodium-hydrogen
exchanger regulatory factor 1; CST3: Cystatin-3; APOB: Apolipoprotein B; APOD: Apolipoprotein D; FAM3B: Pancreatic-derived factor; ITIH1: Inter alpha-
trypsin inhibitor, heavy chain 1; ITIH2: Inter alpha-trypsin inhibitor, heavy chain 2; ITIH4: Inter alpha-trypsin inhibitor, heavy chain 4; RAB1: Ras-related
protein Rab-1A; RAB1: Ras-related protein Rab-1A; RAB2: Ras-related protein Rab-2; RAB11B: Ras-related protein Rab-11B; SERPIND1: Heparin cofactor
2; EHK3: Ephrin type-A receptor 7 CHI3L2: Chitinase-3-like protein 2; Red encircled proteins are shown in more detail in Fig. 3.
doi:10.1371/journal.pone.0122234.g002
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analysis of the proteome showed that the concentrations of several proteins were significantly
different between the breastmilk of allergic and non-allergic mothers (Fig. 3). These results
thus indicate that the difference between breast milk from allergic and non-allergic mothers
lies mainly in the concentration of the proteins and not their absence or presence.
Differences in the milk proteome between allergic and non-allergic
mothers
Fig. 3, presenting data on individual mothers of five proteins, shows that there is considerable
variation between individual mothers. We speculate that this large variation in milk proteome
between individual mothers may be related to the large variation of results in studies on the re-
lation between breastfeeding and asthma/allergy, as previously hypothesized by Matheson et al.
[7]. Some cytokines previously related to tolerance induction (e.g. TGF-β and IL-10) were not
found with our proteomics approach. This is to be expected given the very low concentration
of these components.
The extent of the variation in the five proteins shown in Fig. 3 was similar to that seen for
the other proteins within the entire proteome (see S2 Table for intensity and standard devia-
tions of all proteins). However, for the above five proteins, the difference between mothers
within one group is smaller than the difference between allergic and non-allergic mothers. For
example, LFQ values for cystatin-C (a protease inhibitor) are consistently higher in allergic
mothers than in non-allergic mothers. Based on these data of individual mothers, we conclude
that the significant differences between groups are based on systematic differences between
these groups, and not due to single outlying data points.
When looking more closely at the biological function of the 19 proteins that are significantly
different between the two groups of mothers, one group of proteins is substantially different,
Fig 3. 10log label-free quantification (LFQ) values for five proteins in individual samples from allergic
and non-allergic (control) mothers. Proteins shown are APOD: Apolipoprotein D; CST3: Cystatin-C; ITIH2:
Inter-alpha-trypsin inhibitor heavy chain H2; S100A1: S100 calcium-binding protein A1; TTR: Transthyretin.
p-values are FDR-corrected p-values for t-test by Perseus.
doi:10.1371/journal.pone.0122234.g003
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i.e. the protease inhibitors. Cystatin C, several inter-alpha-trypsin inhibitors, and serine-prote-
ase inhibitors (SERPINS) are all present in higher concentrations in breast milk of allergic
mothers. This seems remarkable, knowing that the major HDM allergen, Der p 1, is itself a pro-
tease and this proteolytic activity has been linked to the mechanisms of the allergic response
[4]. Der p 1 is also known to degrade antiprotease-based lung defences such as mucosal
α1-antitrypsin, which protects the respiratory mucosa against serine proteases [21]. In addi-
tion, it was previously shown that serine proteases and SERPINs are involved in the mainte-
nance of the epithelial barrier of the skin and airways, and that an imbalance of protease-
protease inhibitors allows easier penetration of allergens [22, 23]. For example, reduced cysta-
tin secretion, a protease inhibitor we also detected in breast milk, by epithelial cells has been
linked to easier penetration of Der p 1 through the epidermal barrier [24]. Because this proteo-
lytic activity is considered relevant to the pathogenesis of asthma and allergy, protease inhibi-
tors are being investigated as potential therapeutics for these diseases [23]. Protease inhibitors
have previously been detected in stool of breastfed infants, indicating that these proteins are
not fully digested, and may thus be active in the gastrointestinal tract [25]. In addition to a di-
rect effect, protease inhibitors may also function through protection of other immune proteins
against digestion [26, 27]. In summary, our results, combined with data from the literature in-
dicate that protease inhibitors naturally present in breast milk may be an interesting group of
proteins for further research and study of their potential beneficial effect. A useful next step
would for example be to determine the concentration of protease inhibitors in a larger number
of mothers in which the allergy status of their offspring is known. Unfortunately this was not
possible in our study. However, this would allow assessing whether protease inhibitors in breast
milk are associated with a reduction in the development of asthma and/or allergy in
the offspring.
Next to the protease inhibitors, other milk proteins were found to be differentially expressed
between allergic and non-allergic mothers. For example, apolipoproteins were found to be
over-expressed in the milk of allergic mothers. Like protease inhibitors, apolipoproteins have
been previously linked to asthma and atopy in children [28]; and more recently, their mimetic
peptides have emerged as a potential new treatment for asthma [29]. Furthermore, our study
provides also novel proteins that are different between allergic and non-allergic mothers, like
transthyretin, which is carrier for the thyroid hormone thyroxine, and is also involved in reti-
nol transport. The function of this protein, and other proteins that differed between allergic
and non-allergic mothers, in relation to allergy or breast milk is unknown.
In conclusion, using non-targeted proteomics we identified 19 proteins that significantly
differ between breast milk of allergic and non-allergic mothers. Protease inhibitors were the
largest group of proteins that were upregulated in the milk of allergic mothers. If these results
can be confirmed in future studies, this would show that unbiased milk proteomics analysis
can provide new targets for studies on the relation between allergy and breast
milk composition.
Supporting Information
S1 Table. Time and mode of breast milk collection.
(XLSX)
S2 Table. Overview of all identified protein, including signal intensities (10log LFQ values,
10log IBAQ values), including averages and standard deviation. Proteins present in only al-
lergic or non-allergic mothers, and proteins that differ significantly between groups are indicat-
ed by an X in the respective three columns.
(XLSX)
Milk Proteome of Allergic and Non-Allergic Mothers
PLOS ONE | DOI:10.1371/journal.pone.0122234 March 23, 2015 9 / 11
Acknowledgments
We would like to thank Professor Rob Aalberse for critically reviewing the manuscript.
Author Contributions
Conceived and designed the experiments: KAH FMR AHW. Performed the experiments: KAH
FMR SB. Analyzed the data: KAH FMR LZ GHK DSP JJMV AHW. Wrote the paper: KAH
FMR SB LZ GHK DSP JJMV AHW.
References
1. Walker A. Breast milk as the gold standard for protective nutrients. J Pediatr 2010; 156: S3–7. doi: 10.
1016/j.jpeds.2009.11.021 PMID: 20105662
2. German B, Dillard C, Ward R. Bioactive components in milk. Current opinion in clinical nutrition and
metabolic care 2002; 5: 653–58. PMID: 12394640
3. Newburg DS, Walker WA. Protection of the neonate by the innate immune system of developing gut
and of humanmilk. Pediatr Res 2007; 61: 2–8. PMID: 17211132
4. Verhasselt V. Oral tolerance in neonates: from basics to potential prevention of allergic disease. Muco-
sal Immunol 2010; 3: 326–33. doi: 10.1038/mi.2010.25 PMID: 20485330
5. Belderbos ME, HoubenML, van Bleek GM, Schuijff L, van Uden NO, Bloemen-Carlier EM, et al. Breast-
feeding modulates neonatal innate immune responses: a prospective birth cohort study. Pediatr Allergy
Immunol 2012; 23: 65–74. doi: 10.1111/j.1399-3038.2011.01230.x PMID: 22103307
6. Oberle D, Von Kries R, Von Mutius E. Asthma and breast feeding. Thorax 2001; 56: 896. PMID:
11699502
7. Matheson MC, Allen KJ, Tang MLK. Understanding the evidence for and against the role of breastfeed-
ing in allergy prevention. Clin Exp Allergy 2012; 42: 827–51. doi: 10.1111/j.1365-2222.2011.03925.x
PMID: 22276526
8. van Odijk J, Kull I, Borres MP, Brandtzaeg P, Edberg U, Hanson LA, et al. Breastfeeding and allergic
disease: a multidisciplinary review of the literature (1966–2001) on the mode of early feeding in infancy
and its impact on later atopic manifestations. Allergy 2003; 58: 833–43. PMID: 12911410
9. Bjorksten B, Ait-Khaled N, Innes Asher M, Clayton TO, Robertson C. Global analysis of breast feeding
and risk of symptoms of asthma, rhinoconjunctivitis and eczema in 6–7 year old children: ISAAC Phase
Three. Allergol Immunopathol (Madr) 2011; 39: 318–25. doi: 10.1016/j.aller.2011.02.005 PMID:
21802826
10. Wright AL, Sherrill D, Holberg CJ, Halonen M, Martinez FD. Breast-feeding, maternal IgE, and total
serum IgE in childhood. J Allergy Clin Immunol 1999; 104: 589–94. PMID: 10482832
11. Jarvinen KM, Suomalainen H. Development of cow's milk allergy in breast-fed infants. Clin Exp Allergy
2001; 31: 978–87. PMID: 11467987
12. Loss G, Apprich S, Waser M, Kneifel W, Genuneit J, Buchele G, et al. The protective effect of farm milk
consumption on childhood asthma and atopy: the GABRIELA study. J Allergy Clin Immunol 2011; 128:
766–73.e4. doi: 10.1016/j.jaci.2011.07.048 PMID: 21875744
13. Wijga AH, Kerkhof M, Gehring U, de Jongste JC, Postma DS, Aalberse RC, et al. Cohort profile: The
Prevention and Incidence of Asthma and Mite Allergy (PIAMA) birth cohort. Int J Epidemiol 2013; 11:
11.
14. Wijga AH, van Houwelingen AC, Kerkhof M, Tabak C, de Jongste JC, Gerritsen J, et al. Breast milk
fatty acids and allergic disease in preschool children: the Prevention and Incidence of Asthma and Mite
Allergy birth cohort study. J Allergy Clin Immunol 2006; 117: 440–7. PMID: 16461146
15. Lu J, Boeren S, de Vries SC, van Valenberg HJ, Vervoort J, Hettinga K. Filter-aided sample preparation
with dimethyl labeling to identify and quantify milk fat globule membrane proteins. J Proteomics 2011;
75: 34–43. doi: 10.1016/j.jprot.2011.07.031 PMID: 21907314
16. Hubner NC, Bird AW, Cox J, Splettstoesser B, Bandilla P, Poser I, et al. Quantitative proteomics com-
bined with BAC TransgeneOmics reveals in vivo protein interactions. J Cell Biol 2010; 189: 739–54.
doi: 10.1083/jcb.200911091 PMID: 20479470
17. Huang daW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using
DAVID bioinformatics resources. Nat Protoc 2009; 4: 44–57. doi: 10.1038/nprot.2008.211 PMID:
19131956
Milk Proteome of Allergic and Non-Allergic Mothers
PLOS ONE | DOI:10.1371/journal.pone.0122234 March 23, 2015 10 / 11
18. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass
accuracies and proteome-wide protein quantification. Nat Biotechnol 2008; 26: 1367–72. doi: 10.1038/
nbt.1511 PMID: 19029910
19. Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, ChenW, et al. Global quantifica-
tion of mammalian gene expression control. Nature 2011; 473: 337–42. doi: 10.1038/nature10098
PMID: 21593866
20. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation
response. Proc Natl Acad Sci U S A 2001; 98: 5116–21. PMID: 11309499
21. Jacquet A. The role of the house dust mite-induced innate immunity in development of allergic re-
sponse. Int Arch Allergy Immunol 2011; 155: 95–105. doi: 10.1159/000320375 PMID: 21196753
22. Smith PK, Harper JI. Serine proteases, their inhibitors and allergy. Allergy 2006; 61: 1441–7. PMID:
17073875
23. Gregory LG, Lloyd CM. Orchestrating house dust mite-associated allergy in the lung. Trends Immunol
2011; 32: 402–11. doi: 10.1016/j.it.2011.06.006 PMID: 21783420
24. Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, et al. Epidermal Barrier Dys-
function in Atopic Dermatitis. Journal of Investigative Dermatology 2009; 129: 1892–1908 doi: 10.1038/
jid.2009.133 PMID: 19494826
25. Davidson LA, Lönnerdal B. Fecal alpha1-antitrypsin in breast fed infants is derived from humanmilk
and is not indicative of enteric protein loss. Acta Paediatr Scand 1990; 79: 137–41. PMID: 2321474
26. Lönnerdal Bo. Nutritional and physiologic significance of humanmilk proteins. Am J Clin Nutr 2003; 77:
1537S–1543S PMID: 12812151
27. Zhang L, Boeren S, Hageman JA, van Hooijdonk T, Vervoort J, Hettinga K. Bovine Milk Proteome in
The First 9 Days: Protein Interactions in Maturation of The Immune and Digestive System of The New-
born. PLoS ONE 2015; 10: e0116710. doi: 10.1371/journal.pone.0116710 PMID: 25693162
28. Nagel G, Weiland SK, Rapp K, Link B, Zoellner I, KoenigW. Association of apolipoproteins with symp-
toms of asthma and atopy among schoolchildren. Int Arch Allergy Immunol 2009; 149: 259–66. doi: 10.
1159/000199722 PMID: 19218819
29. Yao X, Remaley AT, Levine SJ. New kids on the block: the emerging role of apolipoproteins in the path-
ogenesis and treatment of asthma. Chest 2011; 140: 1048–54. doi: 10.1378/chest.11-0158 PMID:
21972383
Milk Proteome of Allergic and Non-Allergic Mothers
PLOS ONE | DOI:10.1371/journal.pone.0122234 March 23, 2015 11 / 11
